Similar articles

• Aggrenox: a combination of antiplatelet drugs for stroke prevention.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2000 Feb 7;42(1071):11-2. Med Lett Drugs Ther. 2000. PMID: 10725967 No abstract available.
• Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].

  Kirshner HS. Kirshner HS. Int J Clin Pract. 2007 Oct;61(10):1739-48. doi: 10.1111/j.1742-1241.2007.01515.x. Int J Clin Pract. 2007. PMID: 17877660 Review.
• [Clopidogrel protection is not increased further by ASS!].

  Bogousslavsky J. Bogousslavsky J. Praxis (Bern 1994). 2004 Aug 25;93(35):1390. Praxis (Bern 1994). 2004. PMID: 15468578 German. No abstract available.
• Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.

  Hankey GJ. Hankey GJ. Curr Med Res Opin. 2007 Jun;23(6):1453-62. doi: 10.1185/030079907X199727. Epub 2007 May 17. Curr Med Res Opin. 2007. PMID: 17559741 Review.
• Antiplatelet agents. European perspective.

  Sivenius J, Kaste M. Sivenius J, et al. Adv Neurol. 2003;92:293-9; discussion 301-5. Adv Neurol. 2003. PMID: 12760196 No abstract available.